Managing Director
ohn Wall is a Managing Director with NachmanHaysBrownstein, Inc. Mr Wall is a senior financial and general management professional with strong experience in strategic planning, financial analysis, and computer system implementation. He possesses excellent organizational, communications and interpersonal skills. He has successfully started two companies, turned around troubled business, and managed mergers and acquisitions. He spent 16 years at what became a Fortune 500 company by helping it to grow from $25 million to over $1.2 billion in sales revenues.
Mr. Wall has had strong operational experience in manufacturing and distribution environments with medium-size to Fortune 500 companies. He has served in a variety of financial and accounting roles in both private and public companies and is well experienced in SEC reporting. A self-starter who anticipates problems, he identifies creative solutions and works independently to implement programs. Mr. Wall’s results have consistently improved operations, cut expenses, and enhanced every organization’s bottom line.
As Senior Vice President and Chief Financial Officer of IGI, Inc., Mr. Wall helped to lead the turnaround of the company following removal of the existing management by the company’s Board of Directors. Within 2 months of Mr. Wall joining this AMEX-listed $40 million manufacturer of biotech products, the company’s delayed 10K was filed (with an unqualified opinion from a “Big 5” accounting firm), and public trading in the company’s stock resumed. Mr. Wall led the effort to obtain $29 million in refinancing for this $16 million market cap company, capitalizing upon a turnaround from a $1 million quarterly loss to a $1 million profit one year later. This was achieved by the restoration of positive cash flow and profitability through restructuring and operational efficiency.
Prior to IGI, Mr. Wall was Vice President Finance and CFO at two venture-backed start up companies. As one of the founders of Diversa Corporation, a biotech company that subsequently went public in February 2000, he established the initial operating systems including distribution, computer operations, personnel, finance and accounting. Mr. Wall developed a business plan that raised over $13 million in equity financing and the establishment of a $5 million equipment financing lease line. He also negotiated a corporate joint venture partnership with a $1.5 million equity investment and potential long-term revenues of $50 million.
As one of the founders of GynoPharma, a $20 Million venture capital-backed start up pharmaceutical and medical device manufacturer, Mr. Wall established operating systems including distribution, computer operations, personnel, finance and accounting in order to serve nearly 20,000 customers nationwide. He eventually negotiated the sale of the company to Johnson & Johnson at a substantial multiple of sales.
Mr. Wall spent 16 years at General Cigar Company in a variety of financial and accounting roles, including international controllership responsibilities. He was responsible for site selection and plant development for a 900-person factory in the Dominican Republic. He also helped lead the acquisition and was responsible for the integration of Helme Products, a $50 million manufacturer of tobacco and snack products which included Bachman Foods. He oversaw a $900 Million distribution division with 26 locations in 12 states.
Mr. Wall received his BS degree in accounting from St. Francis College, New York. He is a CPA and a member of the AICPA and the Pennsylvania and New Jersey Societies of CPAs.